Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis | Arthritis Research & Therapy | Full ...
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial | Semantic Scholar
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial - The Lancet
Pharmaceutics | Free Full-Text | Anti-Psoriasis Effect of Diclofenac and Celecoxib Using the Tail Model for Psoriasis
PDF) Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet
ASK DIS: NSAIDS Comparison : Diclofenac, Ibuprofen & Mefenamic Acid
Cardiovascular Risk Associated With NSAIDs and COX-2 Inhibitors
Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients - Chris Walker, Margaret N Essex, Chunming Li, Peter W Park, 2016
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial | Semantic Scholar
Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction - ScienceDirect
Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar
Celecoxib Versus Naproxen and Diclofenac in Osteoarthritis Patients: SUCCESS-I Study - ScienceDirect
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison - The Lancet
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial | Semantic Scholar
Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials | SpringerLink
Selective COX-2 inhibitors: Are they safer NSAIDs?
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar
The structure of (A) Diclofenac, (B) Celecoxib, and (C) Mefenamic acid... | Download Scientific Diagram
Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D1MD00280E
Documento sin título
Celecoxib versus Diclofenac and Omeprazole in Reducing the Risk of Recurrent Ulcer Bleeding in Patients with Arthritis | NEJM
Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study | Annals of the Rheumatic Diseases
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar
Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients - Chris Walker, Margaret N Essex, Chunming Li, Peter W Park, 2016
Blood pressure effects of celecoxib vs diclofenac or ibuprofen | Download Table
Indirect comparison of NSAIDs for ankylosing spondylitis: Network meta‑analysis of randomized, double‑blinded, controlled trials
